248 related articles for article (PubMed ID: 25971623)
1. Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.
Silva VM; de-Araújo CF; Navarro IC; Oliveira PR; Pontes-de-Carvalho L
BMC Res Notes; 2015 May; 8():197. PubMed ID: 25971623
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds.
Silva VM; Larangeira DF; Oliveira PR; Sampaio RB; Suzart P; ; Nihei JS; Teixeira MC; Mengel JO; dos-Santos WL; Pontes-de-Carvalho L
Infect Immun; 2011 Mar; 79(3):1236-43. PubMed ID: 21173308
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
[TBL] [Abstract][Full Text] [Related]
4. Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.
de Araújo CF; Silva VM; Cronemberger-Andrade A; Aragão-França LS; Rocha VC; Santos PS; Pontes-de-Carvalho L
BMC Res Notes; 2014 Feb; 7():70. PubMed ID: 24484604
[TBL] [Abstract][Full Text] [Related]
5. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
6. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
7. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
[TBL] [Abstract][Full Text] [Related]
8. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
9. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.
Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A
Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens.
Pinheiro RO; Pinto EF; Lopes JR; Guedes HL; Fentanes RF; Rossi-Bergmann B
Microbes Infect; 2005 Oct; 7(13):1317-23. PubMed ID: 16027022
[TBL] [Abstract][Full Text] [Related]
11. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
[TBL] [Abstract][Full Text] [Related]
12. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production.
Grenfell RF; Marques-da-Silva EA; Souza-Testasicca MC; Coelho EA; Fernandes AP; Afonso LC; Rezende SA
Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):818-22. PubMed ID: 20944999
[TBL] [Abstract][Full Text] [Related]
13. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
[TBL] [Abstract][Full Text] [Related]
14. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
[TBL] [Abstract][Full Text] [Related]
15. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
[TBL] [Abstract][Full Text] [Related]
16. Detection of serum antibodies against Leishmania 94 kDa antigen in visceral and cutaneous leishmaniosis due to Leishmania infantum.
Rolland L; Belkaid M; Seye A; Schneider P; Gentilini M
Parasite; 1995 Mar; 2(1):13-21. PubMed ID: 9137640
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model.
Ribeiro JG; Ferreira AS; Macedo SRA; Rossi NRDLP; da Silva MCP; Guerra RNM; de Barros NB; Nicolete R
Int Immunopharmacol; 2017 Jun; 47():227-230. PubMed ID: 28433944
[TBL] [Abstract][Full Text] [Related]
19. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
20. Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice.
Velasquez LG; Galuppo MK; DE Rezende E; Brandão WN; Peron JP; Uliana SR; Duarte MI; Stolf BS
Parasitology; 2016 May; 143(6):692-703. PubMed ID: 26892342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
